Capha Pharmaceuticals Inc.
OOTC:FPSUFShare Statistics
As of June 30, 2025, Capha Pharmaceuticals Inc. has 64.43M shares outstanding.
| Shares Outstanding | 64.43M |
Valuation Ratios
These figures are as of June 30, 2025.
| P/TBV Ratio | -0.01 |
| P/FCF Ratio | -0.15 |
| P/OCF Ratio | -0.15 |
Financial Position
As of June 30, 2025, Capha Pharmaceuticals Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2025. Return on assets (ROA) is negative at -1,664.67, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -1,664.67 |
Dividends & Yields
These figures cover the twelve months ended June 30, 2025. Free cash flow yield is negative at -659.75: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -683.99, meaning Capha Pharmaceuticals Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -683.99 |
| FCF Yield | -659.75 |
Stock Splits
Capha Pharmaceuticals Inc.'s most recent stock split took place on August 29, 2014 with a 1:2 split ratio.
| Last Split Date | 8/29/2014 |
| Split Ratio | 1:2 |
Scores
As of June 30, 2025, Capha Pharmaceuticals Inc. has an Altman Z-Score of -5,207.18, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -5,207.18 |